Related Experiment Video
Updated: Jun 23, 2026

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
Published on: October 12, 2014
Insights
Orthotopic cardiac transplantation is a viable treatment for end-stage heart disease, offering high survival and rehabilitation rates. Advances in immunosuppression are key to improving long-term outcomes for heart transplant patients.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- End-stage heart disease (EHD) significantly impacts patient prognosis.
- Inoperable EHD necessitates advanced therapeutic interventions.
- Cardiac transplantation is a potential solution for select EHD patients.
Purpose of the Study:
- To evaluate orthotopic cardiac transplantation as a treatment for inoperable end-stage heart disease.
- To assess survival and rehabilitation outcomes following cardiac transplantation.
- To identify factors influencing survival rates in heart transplant recipients.
Main Methods:
- Retrospective analysis of 188 patients undergoing orthotopic cardiac transplantation at Stanford.
- Comparison of survival rates with cadaver renal transplant series.
- Assessment of patient rehabilitation potential.
Main Results:
- Orthotopic cardiac transplantation is a reasonable therapeutic option for patients with inoperable end-stage heart disease.
- Survival expectations are comparable to cadaver renal transplantation.
- Rehabilitation potential exceeds 90% for eligible patients.
Conclusions:
- Cardiac transplantation offers significant benefits for patients with inoperable end-stage heart disease.
- Current survival limitations are primarily linked to immunosuppression strategies.
- Future advancements in immunosuppression are expected to enhance cardiac transplant outcomes.
Abstract:
Based on the Stanford series of 188 patients, we emphasize that orthotopic cardiac transplantation represents a reasonable therapeutic option for the patient with inoperable end-stage heart disease. Current expectations for survival equal those for organ survival in cadaver renal transplant series and offer a rehabilitation potential of over 90%. Most of the complications limiting survival are due to the currently available means of immunosuppression and, therefore, advances in the field of immunosuppression can be expected to have a major positive influence on survival rates.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy V: Interprofessional Care
Kidney Transplant I: Introduction

